Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity
Authors
Keywords
-
Journal
BMJ Open Gastroenterology
Volume 9, Issue 1, Pages e000871
Publisher
BMJ
Online
2022-05-24
DOI
10.1136/bmjgast-2022-000871
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome
- (2022) Qin Liu et al. GUT
- Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
- (2021) Yun Kit Yeoh et al. GUT
- Negative Association Between Mediterranean Diet Adherence and COVID-19 Cases and Related Deaths in Spain and 23 OECD Countries: An Ecological Study
- (2021) Michael W. Greene et al. Frontiers in Nutrition
- The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia
- (2021) Luisa Marras et al. Microorganisms
- Inhibitory effect of Bifidobacterium Bifidum ATCC 29521 on colitis and its mechanism
- (2020) Ahmad Ud Din et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms
- (2020) Xi Jin et al. GUT
- Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies
- (2020) Ming Zhao INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza
- (2020) Silan Gu et al. CLINICAL INFECTIOUS DISEASES
- Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19
- (2020) Tao Zuo et al. GUT
- Is a healthy microbiome responsible for lower mortality in COVID-19?
- (2020) Lubomír Janda et al. BIOLOGIA
- Immunological co-ordination between gut and lungs in SARS-CoV-2 infection
- (2020) Shruti Ahlawat et al. VIRUS RESEARCH
- Probiotics at War Against Viruses: What Is Missing From the Picture?
- (2020) Santosh Kumar Tiwari et al. Frontiers in Microbiology
- Probiotics in Medicine: A Long Debate
- (2020) Elisavet Stavropoulou et al. Frontiers in Immunology
- Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection
- (2020) David Groeger et al. EBioMedicine
- Viral Infection-Induced Gut Dysbiosis, Neuroinflammation, and α-Synuclein Aggregation: Updates and Perspectives on COVID-19 and Neurodegenerative Disorders
- (2020) Cristian Follmer ACS Chemical Neuroscience
- Controlling Cytokine Storm Is Vital in COVID-19
- (2020) Lu Tang et al. Frontiers in Immunology
- Potential Role of Gut Microbiota in Induction and Regulation of Innate Immune Memory
- (2019) Shikha Negi et al. Frontiers in Immunology
- Exopolysaccharide from Bifidobacterium longum subsp. longum 35624™ modulates murine allergic airway responses
- (2018) E. Schiavi et al. Beneficial Microbes
- Protective Effects of Bifidobacterial Strains Against Toxigenic Clostridium difficile
- (2018) Yanxia Wei et al. Frontiers in Microbiology
- Causal Relationship between Diet-Induced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes
- (2018) Kumar Ganesan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bifidobacterium brevereduces apoptotic epithelial cell shedding in an exopolysaccharide and MyD88-dependent manner
- (2017) K. R. Hughes et al. Open Biology
- Bifidobacteria and Their Molecular Communication with the Immune System
- (2017) Lorena Ruiz et al. Frontiers in Microbiology
- Role of antibiotics for treatment of inflammatory bowel disease
- (2016) Orna Nitzan WORLD JOURNAL OF GASTROENTEROLOGY
- The healthy human microbiome
- (2016) Jason Lloyd-Price et al. Genome Medicine
- Effect of Bifidobacterium upon Clostridium difficile Growth and Toxicity When Co-cultured in Different Prebiotic Substrates
- (2016) L. Valdés-Varela et al. Frontiers in Microbiology
- Gut Bifidobacteria Populations in Human Health and Aging
- (2016) Silvia Arboleya et al. Frontiers in Microbiology
- The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
- (2014) Aleksandar D. Kostic et al. GASTROENTEROLOGY
- Summer Meeting 2013: growth and physiology of bifidobacteria
- (2013) L. De Vuyst et al. JOURNAL OF APPLIED MICROBIOLOGY
- Immunomodulation by Bifidobacterium infantis 35624 in the Murine Lamina Propria Requires Retinoic Acid-Dependent and Independent Mechanisms
- (2013) Patrycja Konieczna et al. PLoS One
- Tumor Necrosis Factor-α Signaling in Macrophages
- (2012) Narayanan Parameswaran et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection
- (2012) S. Fanning et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis
- (2011) David Philippe et al. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
- Evaluation of in vitro antagonism and of in vivo immune modulation and protection against pathogenic experimental challenge of two probiotic strains of Bifidobacterium animalis var. lactis
- (2010) Ariane K. S. Martins et al. ARCHIVES OF MICROBIOLOGY
- Through Ageing, and Beyond: Gut Microbiota and Inflammatory Status in Seniors and Centenarians
- (2010) Elena Biagi et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More